[go: up one dir, main page]

DE69433210D1 - VERFAHEN ZUR GLEICHZEITIGEN IDENTIFIKATION VON DIFFERENTIELLE EXPRIMIERTEN mRNA'S UND ZUR MESSUNG IHRER RELATIVEN KONZENTRATION - Google Patents

VERFAHEN ZUR GLEICHZEITIGEN IDENTIFIKATION VON DIFFERENTIELLE EXPRIMIERTEN mRNA'S UND ZUR MESSUNG IHRER RELATIVEN KONZENTRATION

Info

Publication number
DE69433210D1
DE69433210D1 DE69433210T DE69433210T DE69433210D1 DE 69433210 D1 DE69433210 D1 DE 69433210D1 DE 69433210 T DE69433210 T DE 69433210T DE 69433210 T DE69433210 T DE 69433210T DE 69433210 D1 DE69433210 D1 DE 69433210D1
Authority
DE
Germany
Prior art keywords
cdna
mrna
primers
crna
derived
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69433210T
Other languages
English (en)
Inventor
Mark G Erlander
Gregor J Sutcliffe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Scripps Research Institute
Original Assignee
Scripps Research Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Research Institute filed Critical Scripps Research Institute
Application granted granted Critical
Publication of DE69433210D1 publication Critical patent/DE69433210D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1096—Processes for the isolation, preparation or purification of DNA or RNA cDNA Synthesis; Subtracted cDNA library construction, e.g. RT, RT-PCR
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6853—Nucleic acid amplification reactions using modified primers or templates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Plant Pathology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DE69433210T 1993-11-12 1994-11-14 VERFAHEN ZUR GLEICHZEITIGEN IDENTIFIKATION VON DIFFERENTIELLE EXPRIMIERTEN mRNA'S UND ZUR MESSUNG IHRER RELATIVEN KONZENTRATION Expired - Lifetime DE69433210D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/152,482 US5459037A (en) 1993-11-12 1993-11-12 Method for simultaneous identification of differentially expressed mRNAs and measurement of relative concentrations
PCT/US1994/013041 WO1995013369A1 (en) 1993-11-12 1994-11-14 METHOD FOR SIMULTANEOUS IDENTIFICATION OF DIFFERENTIALLY EXPRESSED mRNAs AND MEASUREMENT OF RELATIVE CONCENTRATIONS

Publications (1)

Publication Number Publication Date
DE69433210D1 true DE69433210D1 (de) 2003-11-06

Family

ID=22543116

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69433210T Expired - Lifetime DE69433210D1 (de) 1993-11-12 1994-11-14 VERFAHEN ZUR GLEICHZEITIGEN IDENTIFIKATION VON DIFFERENTIELLE EXPRIMIERTEN mRNA'S UND ZUR MESSUNG IHRER RELATIVEN KONZENTRATION

Country Status (9)

Country Link
US (6) US5459037A (de)
EP (1) EP0726946B1 (de)
JP (1) JPH09509306A (de)
AT (1) ATE251220T1 (de)
CA (1) CA2174966A1 (de)
DE (1) DE69433210D1 (de)
FI (1) FI962000A0 (de)
NO (1) NO961902L (de)
WO (1) WO1995013369A1 (de)

Families Citing this family (91)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5545522A (en) 1989-09-22 1996-08-13 Van Gelder; Russell N. Process for amplifying a target polynucleotide sequence using a single primer-promoter complex
US7049102B1 (en) 1989-09-22 2006-05-23 Board Of Trustees Of Leland Stanford University Multi-gene expression profile
US5459037A (en) * 1993-11-12 1995-10-17 The Scripps Research Institute Method for simultaneous identification of differentially expressed mRNAs and measurement of relative concentrations
US6110680A (en) * 1993-11-12 2000-08-29 The Scripps Research Institute Method for simultaneous identification of differentially expressed mRNAs and measurement of relative concentrations
US6096503A (en) * 1993-11-12 2000-08-01 The Scripps Research Institute Method for simultaneous identification of differentially expresses mRNAs and measurement of relative concentrations
RU2111254C1 (ru) * 1994-07-11 1998-05-20 Институт молекулярной биологии им.В.А.Энгельгардта РАН СПОСОБ ДЕТЕКЦИИ ДИФФЕРЕНЦИАЛЬНО ЭКСПРЕССИРУЮЩИХСЯ МАТРИЧНЫХ РНК И КЛОНИРОВАНИЯ СООТВЕТСТВУЮЩИХ ИМ ФРАГМЕНТОВ кДНК
IT1275909B1 (it) * 1995-03-07 1997-10-24 Mirella Pilone Frammento di dna codificante d-amminoacido ossidasi
DE69621507T2 (de) * 1995-03-28 2003-01-09 Japan Science And Technology Corp., Kawaguchi Verfahren zur molekularen Indexierung von Genen unter Verwendung von Restriktionsenzymen
US6395887B1 (en) 1995-08-01 2002-05-28 Yale University Analysis of gene expression by display of 3'-end fragments of CDNAS
US5712126A (en) * 1995-08-01 1998-01-27 Yale University Analysis of gene expression by display of 3-end restriction fragments of CDNA
US5866330A (en) * 1995-09-12 1999-02-02 The Johns Hopkins University School Of Medicine Method for serial analysis of gene expression
US6418382B2 (en) 1995-10-24 2002-07-09 Curagen Corporation Method and apparatus for identifying, classifying, or quantifying DNA sequences in a sample without sequencing
US5871697A (en) 1995-10-24 1999-02-16 Curagen Corporation Method and apparatus for identifying, classifying, or quantifying DNA sequences in a sample without sequencing
US5972693A (en) * 1995-10-24 1999-10-26 Curagen Corporation Apparatus for identifying, classifying, or quantifying DNA sequences in a sample without sequencing
WO1997029211A1 (en) * 1996-02-09 1997-08-14 The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services RESTRICTION DISPLAY (RD-PCR) OF DIFFERENTIALLY EXPRESSED mRNAs
US6017903A (en) 1996-09-27 2000-01-25 Guilford Pharmaceuticals Inc. Pharmaceutical compositions and methods of treating a glutamate abnormality and effecting a neuronal activity in an animal using NAALADase inhibitors
US5824662A (en) * 1996-09-27 1998-10-20 Guilford Pharmaceuticals Inc. Treatment of global and focal ischemia using naaladase inhibitors
EP1007730A4 (de) 1996-08-30 2004-04-28 Invitrogen Corp Verfahren zur identifizierung und isolierung von spezifischen nukleotidsequenzen in cdna und genomischer dna
CZ60499A3 (cs) 1996-09-27 1999-08-11 Guilford Pharmaceuticals Inc. Prostředky s účinkem na NAALADázy, způsoby léčení glutamátové abnormality a způsoby ovlivňování neuronální aktivity u živočichů
US6013437A (en) * 1996-11-12 2000-01-11 Qbi Enterprises, Ltd. Method for identifying translationally regulated genes
EP0942969A1 (de) * 1996-11-12 1999-09-22 Qbi Enterprises Ltd. Verfahren zur identifizierung von genen welche auf der stufe der translation reguliert werden
AU722819B2 (en) * 1996-12-06 2000-08-10 Urocor, Inc. Diagnosis of disease state using mRNA profiles
US5968784A (en) * 1997-01-15 1999-10-19 Chugai Pharmaceutical Co., Ltd. Method for analyzing quantitative expression of genes
US6461814B1 (en) 1997-01-15 2002-10-08 Dominic G. Spinella Method of identifying gene transcription patterns
US6306588B1 (en) 1997-02-07 2001-10-23 Invitrogen Corporation Polymerases for analyzing or typing polymorphic nucleic acid fragments and uses thereof
US7332270B1 (en) 1997-03-24 2008-02-19 Urocor, Inc. Diagnosis of disease state using mRNA profiles in peripheral leukocytes
US6190857B1 (en) 1997-03-24 2001-02-20 Urocor, Inc. Diagnosis of disease state using MRNA profiles in peripheral leukocytes
US5958688A (en) * 1997-04-28 1999-09-28 The Trustees Of The University Of Pennsylvania Characterization of mRNA patterns in neurites and single cells for medical diagnosis and therapeutics
WO1998049345A1 (en) * 1997-04-29 1998-11-05 Trustees Of Boston University Methods and compositions for targeted dna differential display
US6261770B1 (en) 1997-05-13 2001-07-17 Display Systems Biotech Aps Method to clone mRNAs
DK0981609T3 (da) * 1997-05-13 2001-11-12 Azign Bioscience As Fremgangsmåde til kloning af mRNA'er og display af differentielt udtrykte transkripter (DODET)
US6373971B1 (en) * 1997-06-12 2002-04-16 International Business Machines Corporation Method and apparatus for pattern discovery in protein sequences
CA2298140A1 (en) * 1997-08-07 1999-02-18 Curagen Corporation Detection and confirmation of nucleic acid sequences by use of oligonucleotides comprising a subsequence hybridizing exactly to a known terminal sequence and a subsequence hybridizing to an unidentified sequence
AU1603199A (en) * 1997-12-03 1999-06-16 Curagen Corporation Methods and devices for measuring differential gene expression
DK1052292T3 (da) 1997-12-22 2003-07-28 Genset Sa Prostatacancer-gen
US7189833B2 (en) * 1997-12-22 2007-03-13 Serono Genetics Institute S.A. Prostate cancer gene
US5945522A (en) * 1997-12-22 1999-08-31 Genset Prostate cancer gene
US6265546B1 (en) 1997-12-22 2001-07-24 Genset Prostate cancer gene
US5972615A (en) * 1998-01-21 1999-10-26 Urocor, Inc. Biomarkers and targets for diagnosis, prognosis and management of prostate disease
DE19806431C1 (de) * 1998-02-17 1999-10-14 Novartis Ag Neues Verfahren zur Identifikation und Charakterisierung von mRNA-Molekülen
IL133673A0 (en) * 1998-05-11 2001-04-30 Quark Biotech Inc Method for identifying genes
DE19822287C2 (de) 1998-05-18 2003-04-24 Switch Biotech Ag Klonierungsvektor, seine Herstellung und Verwendung zur Analyse von mRNA Expressionsmuster
WO2000018966A2 (en) * 1998-09-29 2000-04-06 Arch Development Corporation A new strategy for genome-wide gene analysis: integrated procedures for gene identification
KR20010092721A (ko) * 1998-11-04 2001-10-26 추후제출 발현된 메신저 rna의 상대적인 농도를 산출하고 결정하는방법
US20020012922A1 (en) * 1998-11-04 2002-01-31 Hilbush Brian S. Simplified method for indexing and determining the relative concentration of expressed messenger RNAs
WO2000028090A2 (en) 1998-11-12 2000-05-18 Nyxis, Inc. Diagnostic assay for cancer
US6750012B1 (en) * 1998-12-21 2004-06-15 Curagen Corporation Method of identifying a psychotropic agent using differential gene expression
US6429302B1 (en) 1999-02-02 2002-08-06 Chiron Corporation Polynucleotides related to pancreatic disease
US20060234246A1 (en) * 1999-02-02 2006-10-19 Chiron Corporation Gene products differentially expressed in cancerous cells
AU4342800A (en) * 1999-04-12 2000-11-14 Digital Gene Technologies, Inc. Differential regulation of gene expression in oncogenic transformation
AU4562700A (en) * 1999-05-05 2000-11-21 European Molecular Biology Laboratory Improved predictive power of rna analysis for protein expression
US6334099B1 (en) 1999-05-25 2001-12-25 Digital Gene Technologies, Inc. Methods for normalization of experimental data
US7838225B2 (en) * 1999-10-29 2010-11-23 Hologic, Inc. Methods for detection of a target nucleic acid by forming a cleavage structure using a reverse transcriptase
AU1466001A (en) * 1999-11-05 2001-05-14 Phase-1 Molecular Toxicology Methods of determining individual hypersensitivity to an agent
WO2001048242A2 (en) 1999-12-29 2001-07-05 Mergen Ltd. Methods for amplifying and detecting multiple polynucleotides on a solid phase support
EP1410301A4 (de) * 2000-04-12 2008-01-23 Cleveland Clinic Foundation System zum identifizieren und analysieren der expression von are-haltigen genen
US6387624B1 (en) * 2000-04-14 2002-05-14 Incyte Pharmaceuticals, Inc. Construction of uni-directionally cloned cDNA libraries from messenger RNA for improved 3′ end DNA sequencing
DK1290444T3 (da) 2000-06-14 2010-01-18 Vistagen Inc Toxicitetstypisering under anvendelse af lever-stamceller
AU7970401A (en) * 2000-06-30 2002-01-14 Syngenta Participations Ag Method for identification, separation and quantitative measurement of nucleic acid fragments
US7300751B2 (en) * 2000-06-30 2007-11-27 Syngenta Participations Ag Method for identification of genetic markers
US20040166499A1 (en) 2000-10-05 2004-08-26 Yoshihide Hayashizaki Oligonucleotide linkers comprising a variable cohesive portion and method for the praparation of polynucleotide libraries by using said linkers
US6391592B1 (en) * 2000-12-14 2002-05-21 Affymetrix, Inc. Blocker-aided target amplification of nucleic acids
US6727068B2 (en) 2001-01-24 2004-04-27 Syngenta Participations Ag Method for non-redundant library construction
US20030165865A1 (en) * 2001-01-29 2003-09-04 Hinkel Christopher A. Methods of analysis of nucleic acids
DE10114063A1 (de) * 2001-03-22 2002-10-10 Mpb Cologne Gmbh Molecular Pla Neue Pflanzengene und deren Verwendung zur Isolierung von konstitutiven oder induzierbaren Promotoren
CA2441893C (en) 2001-03-26 2015-01-20 Dana-Farber Cancer Institute, Inc. Method of attenuating reactions to skin irritants
US6949340B2 (en) 2001-03-28 2005-09-27 Creative Mines Llc Optical phase modulator
US7235358B2 (en) 2001-06-08 2007-06-26 Expression Diagnostics, Inc. Methods and compositions for diagnosing and monitoring transplant rejection
US6905827B2 (en) 2001-06-08 2005-06-14 Expression Diagnostics, Inc. Methods and compositions for diagnosing or monitoring auto immune and chronic inflammatory diseases
US7026121B1 (en) 2001-06-08 2006-04-11 Expression Diagnostics, Inc. Methods and compositions for diagnosing and monitoring transplant rejection
JP4455876B2 (ja) 2001-06-22 2010-04-21 ステムセルズ インコーポレーティッド 肝移植細胞、アッセイ法、およびその使用法
US20030082584A1 (en) * 2001-06-29 2003-05-01 Liang Shi Enzymatic ligation-based identification of transcript expression
US20030170695A1 (en) * 2001-06-29 2003-09-11 Liang Shi Enzymatic ligation-based identification of nucleotide sequences
US20030170661A1 (en) * 2001-07-23 2003-09-11 Yi Liu Method for identifying a nucleic acid sequence
US20120077196A9 (en) * 2001-09-03 2012-03-29 Guido Krupp Universal method for selective amplification of mRNAs
DE10143106C1 (de) * 2001-09-03 2002-10-10 Artus Ges Fuer Molekularbiolog Vermehrung von Ribonukleinsäuren
DE10240868A1 (de) * 2002-09-04 2004-03-18 Artus Gesellschaft für molekularbiologische Diagnostik und Entwicklung mbH Verbesserte Verfahren zur Synthese von Nukleinsäuren
US20050003369A1 (en) * 2002-10-10 2005-01-06 Affymetrix, Inc. Method for depleting specific nucleic acids from a mixture
US7892745B2 (en) 2003-04-24 2011-02-22 Xdx, Inc. Methods and compositions for diagnosing and monitoring transplant rejection
US20050042660A1 (en) * 2003-07-31 2005-02-24 Hall Gerald Edward Devices and methods for isolating RNA
US20050026175A1 (en) * 2003-07-31 2005-02-03 John Link Devices and methods for isolating RNA
US20060099605A1 (en) * 2004-11-11 2006-05-11 Hall Gerald E Jr Devices and methods for isolating RNA
WO2006029184A2 (en) 2004-09-08 2006-03-16 Expression Diagnostics, Inc. Genes useful for diagnosing and monitoring inflammation related disorders
WO2006101487A1 (en) * 2005-03-18 2006-09-28 The Board Of Trustees Of The Leland Stanford Junior University Production and therapeutic uses of th1-like regulatory t cells
US20060270843A1 (en) * 2005-05-26 2006-11-30 Hall Gerald E Jr Methods for isolation of nucleic acids
US7666584B2 (en) * 2005-09-01 2010-02-23 Philadelphia Health & Education Coporation Identification of a pin specific gene and protein (PIN-1) useful as a diagnostic treatment for prostate cancer
WO2008021431A2 (en) 2006-08-14 2008-02-21 Xdx, Inc. Methods and compositions for diagnosing and monitoring the status of transplant rejection and immune disorders
WO2008140484A2 (en) 2006-11-09 2008-11-20 Xdx, Inc. Methods for diagnosing and monitoring the status of systemic lupus erythematosus
CA2693144A1 (en) 2007-07-17 2009-01-22 The General Hospital Corporation Methods to identify and enrich for populations of ovarian cancer stem cells and somatic ovarian stem cells and uses thereof
US8669048B2 (en) 2008-06-24 2014-03-11 Parkinson's Institute Pluripotent cell lines and methods of use thereof
WO2013065763A1 (ja) * 2011-10-31 2013-05-10 独立行政法人理化学研究所 幹細胞の培養方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100242252B1 (ko) * 1989-07-11 2000-03-02 다니엘 엘. 캐시앙 핵산서열의 증폭방법
CA2111472A1 (en) * 1991-06-14 1992-12-23 Brett P. Monia Antisense oligonucleotide inhibition of the ras gene
WO1993018176A1 (en) * 1992-03-11 1993-09-16 Dana-Farber Cancer Institute METHODS TO CLONE mRNA
US6110680A (en) * 1993-11-12 2000-08-29 The Scripps Research Institute Method for simultaneous identification of differentially expressed mRNAs and measurement of relative concentrations
US6096503A (en) * 1993-11-12 2000-08-01 The Scripps Research Institute Method for simultaneous identification of differentially expresses mRNAs and measurement of relative concentrations
US5459037A (en) * 1993-11-12 1995-10-17 The Scripps Research Institute Method for simultaneous identification of differentially expressed mRNAs and measurement of relative concentrations
US5866330A (en) * 1995-09-12 1999-02-02 The Johns Hopkins University School Of Medicine Method for serial analysis of gene expression
US5994068A (en) * 1997-03-11 1999-11-30 Wisconsin Alumni Research Foundation Nucleic acid indexing

Also Published As

Publication number Publication date
WO1995013369A1 (en) 1995-05-18
US5459037A (en) 1995-10-17
EP0726946A4 (de) 1999-02-10
NO961902D0 (no) 1996-05-10
EP0726946B1 (de) 2003-10-01
EP0726946A1 (de) 1996-08-21
US20030092006A1 (en) 2003-05-15
AU1055195A (en) 1995-05-29
FI962000A7 (fi) 1996-05-10
AU687127B2 (en) 1998-02-19
ATE251220T1 (de) 2003-10-15
JPH09509306A (ja) 1997-09-22
FI962000L (fi) 1996-05-10
FI962000A0 (fi) 1996-05-10
US5807680A (en) 1998-09-15
US6309834B1 (en) 2001-10-30
US20020127571A1 (en) 2002-09-12
NO961902L (no) 1996-07-12
US6030784A (en) 2000-02-29
CA2174966A1 (en) 1995-05-18

Similar Documents

Publication Publication Date Title
DE69433210D1 (de) VERFAHEN ZUR GLEICHZEITIGEN IDENTIFIKATION VON DIFFERENTIELLE EXPRIMIERTEN mRNA'S UND ZUR MESSUNG IHRER RELATIVEN KONZENTRATION
MXPA00012757A (es) Metodo mejorado para identificacion simultanea de arnm expresados diferencialmente y medicion de concetraciones relativas.
Okamoto et al. CD44 cleavage induced by a membrane-associated metalloprotease plays a critical role in tumor cell migration
Geradts et al. Human lung cancer cell lines exhibit resistance to retinoic acid treatment.
Gooding et al. Smooth muscle‐specific switching of alpha‐tropomyosin mutually exclusive exon selection by specific inhibition of the strong default exon.
EP0861334B2 (de) Verfahren zur quantifizierung von tumorzellen in einer körperflüssigkeit und dazu geeignete testkits
Gerlitz The emerging roles of heterochromatin in cell migration
Breit et al. Suppression of MYC by high expression of NMYC in human neuroblastoma cells
ATE179754T1 (de) Verfahren zur herstellung von thrombin
CA2464691A1 (en) Methods and systems for dynamic gene expression profiling
ATE189264T1 (de) Chimärisches oligonukleotid und dessen verwendung zur herstellung von nukleinsäure-transkripten
ATE253647T1 (de) Verfahren und zusammensetzung zur detektion pathogener zustände
DE50115872D1 (de) Verfahren zur herstellung eines bioanalytischen reagenzes, nachweisverfahren beruhend auf der verwendung des bioanalytischen reagenz, sowie dessen verwendung
ES2018916A6 (es) Un metodo de ensayo de hibridacion de acidos nucleicos.
Sen et al. Identification of the messenger RNAs coding for the gag and env gene products of the murine mammary tumor virus
Rosson et al. Constitutive c-myb expression in K562 cells inhibits induced erythroid differentiation but not tetradecanoyl phorbol acetate-induced megakaryocytic differentiation
CN106434982A (zh) 缺血性脑卒中相关的分子标记物及其应用
EA200100490A1 (ru) Способ индексации и определения относительной концентрации экспрессирующихся информационных рнк
Linqing et al. Runx1t1 regulates the neuronal differentiation of radial glial cells from the rat hippocampus
Pugach et al. The use of mouse models to investigate shear bond strength in amelogenesis imperfecta
Hale et al. Expression of CD44 variants in human inflammatory synovitis
Leibovitch et al. Possible role of c-fos, cN-ras and c-mos proto-oncogenes in muscular development
Munns et al. Effects of estradiol on uterine ribonucleic acid metabolism. II. Methylation of ribosomal ribonucleic acid and trannsfer ribonucleic acid
Grayson et al. Estimation of the half-life of a secretory protein message
Oh et al. Regulation of Na+ channel β1 and β2 subunit mRNA levels in cultured rat astrocytes

Legal Events

Date Code Title Description
8332 No legal effect for de